Retraction notice to “Aberrant frequency of IL-10-producing b cells and its association with Treg and MDSC cells in Non Small Cell Lung Carcinoma patients” [Hum. Immunol. 77 (1) (2016) 84–89] (Human Immunology (2016) 77(1) (84–89), (S0198885915005364), (10.1016/j.humimm.2015.10.015));Aberrant frequency of IL-10-producing B cells and its association with Treg and MDSC cells in Non Small Cell Lung Carcinoma patients

Human Immunology

Volumn 77, Issue 1, 2016, Pages 84-89

  Liu, Jinlin ^a   Wang, Huan ^a   Yu, Qinhua ^a   Zheng, Sujie ^a   Jiang, Yangcheng ^b   Liu, Yiyan ^b   Yuan, Guorong ^a   Qiu, Liannv ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

IL 10 producing B cells; Non Small Cell Lung Carcinoma

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 7 RECEPTOR; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER GROWTH; CANCER PATIENT; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IL 10 PRODUCING B CELL; MAJOR CLINICAL STUDY; MALE; MYELOID DERIVED SUPPRESSOR CELL; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; UPREGULATION; BONE MARROW CELL; CANCER STAGING; CARCINOGENESIS; IMMUNOLOGY; LUNG TUMOR; METABOLISM; MIDDLE AGED;

ANTIGENS, CD; B-LYMPHOCYTES, REGULATORY; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; LUNG NEOPLASMS; MALE; MIDDLE AGED; MYELOID CELLS; NEOPLASM STAGING; T-LYMPHOCYTES, REGULATORY;

EID: 84951310664     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2020.01.001     Document Type: Erratum

References (21)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62:10.
2. Suzuki K., Kachala S.S., Kadota K., Shen R., Mo Q., Beer D.G., et al. Prognostic immune markers in non-small cell lung cancer. Clin. Cancer Res. 2011, 17:5247.
3. De Vita F., Orditura M., Galizia G., Romano C., Roscigno A., Lieto E., et al. Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest 2000, 117:365.
4. Baratelli F., Lee J.M., Hazra S., Lin Y., Walser T.C., Schaue D., et al. PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Am. J. Transl. Res. 2010, 2:356.
5. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162.
6. Hoechst B., Ormandy L.A., Ballmaier M., Lehner F., Kruger C., Manns M.P., et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008, 135:234.
7. Lin Y., Gustafson M.P., Bulur P.A., Gastineau D.A., Witzig T.E., Dietz A.B. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma. Blood 2011, 117:872.
8. Huang A., Zhang B., Wang B., Zhang F., Fan K.X., Guo Y.J. Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. Cancer Immunol. Immunother. 2013, 62:1439.
9. Mauri C., Bosma A. Immune regulatory function of B cells. Annu. Rev. Immunol. 2012, 30:221.
10. Balkwill F., Montfort A., Capasso M. B regulatory cells in cancer. Trends Immunol. 2013, 34:169.
11. Wilde B., Thewissen M., Damoiseaux J., Knippenberg S., Hilhorst M., van Paassen P., et al. Regulatory B cells in ANCA-associated vasculitis. Ann. Rheum. Dis. 2013, 72:1416.
12. Watanabe R., Ishiura N., Nakashima H., Kuwano Y., Okochi H., Tamaki K., et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J. Immunol. 2010, 184:4801.
13. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129.
14. Flores-Borja F., Bosma A., Ng D., Reddy V., Ehrenstein M.R., Isenberg D.A., et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 2013, 5. 173ra23.
15. Iwata Y., Matsushita T., Horikawa M., Dilillo D.J., Yanaba K., Venturi G.M., et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011, 117:530.
16. DiLillo D.J., Weinberg J.B., Yoshizaki A., Horikawa M., Bryant J.M., Iwata Y., et al. Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia 2013, 27:170.
17. Shao Y., Lo C.M., Ling C.C., Liu X.B., Ng K.T., Chu A.C., et al. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. Cancer Lett. 2014, 355:264.
18. Zhou J., Min Z., Zhang D., Wang W., Marincola F., Wang X. Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer. J. Transl. Med. 2014, 12:304.
19. Detterbeck F.C., Boffa D.J., Tanoue L.T. The new lung cancer staging system. Chest 2009, 136:260.
20. Lindau D., Gielen P., Kroesen M., Wesseling P., Adema G.J. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 2013, 138:105.
21. Cherukuri A., Rothstein D.M., Clark B., Carter C.R., Davison A., Hernandez-Fuentes M., et al. Immunologic human renal allograft injury associates with an altered IL-10/TNF-alpha expression ratio in regulatory B cells. J. Am. Soc. Nephrol. 2014, 25:1575.